Abstract

Nuclear methods play an important role in medicine, both in diagnosis and therapy. The status of nuclear data with regard to the production of commonly used diagnostic and therapeutic radionuclides is discussed. The new trends and data needs in the development of potentially useful radionuclides are outlined. They pertain to longer-lived positron emitters (e.g., 64Cu, 76Br, 124I) for studying slow metabolic processes, to positron emitters needed for quantification purposes (94mTc, 86Y, etc.) and to soft radiation emitting therapeutic radionuclides (103Pd, 186Re, 225Ac, etc.). The imaging problems with new positron emitters are discussed. As regards radiation therapy, data on the formation of short-lived activation products in proton therapy are reported.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call